Back to BARCLAYS PLC BARCLAYS PLC

TRVITRVI
Showing 8 of 18 quarters

Position history for BARCLAYS PLCBARCLAYS PLC's holdings in Trevi Therapeutics, Inc.

BARCLAYS PLC holds 1.1M shares of TRVI (Trevi Therapeutics, Inc.), worth $21.3M as of 2026-Q2. The position was increased (+2031.3% shares). TRVI represents 0.0% of BARCLAYS PLC's portfolio.

Current Value

$21.3M

Current Shares

1.1M

Total Value Change

+$21M

Total Shares Change

+1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.1M
+2031.3%
$21.3M0.0%$18.65
46
2026-Q1
Decreased
53,585
-90.8%
$639,2680.0%$12.26
0
2025-Q4
Increased
582,653
+168.7%
$7.3M0.0%$12.56
44
2025-Q3
Decreased
216,885
-57.9%
$2M0.0%$8.95
0
2025-Q2
Increased
515,476
+273.7%
$2.8M0.0%$5.62
42
2025-Q1
Decreased
137,932
-11.7%
$867,5930.0%$6.50
0
2024-Q4
Increased
156,267
+64.1%
$643,8200.0%$4.10
36
2024-Q3
Increased
95,232
+180.8%
$318,0750.0%$3.33
38

Other major holders of TRVI: FMR LLC, BlackRock, Inc., WELLINGTON MANAGEMENT GROUP LLP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used